"I didn’t leave you for four months. I got a staph infection because I lived in a hospital,” Kardashian told Odom when they ...
Health and Me on MSN
Weight loss drug semaglutide cannot slow down Alzheimer’s: Lancet study
Evoke and Evoke+ -- the randomized, double-blind, placebo-controlled phase 3 trials conducted across 566 sites in 40 countries -- showed that semaglutide led to no significant difference after two ...
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...
About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...
Experts answer four key questions based on the findings of a study that indicated that low-dose oral lithium could slow ...
Medical Device Network on MSN
Nia Therapeutics plans FIH memory loss implant trial after FDA green light
Nia Therapeutics' Smart Neurostimulation System (SNS) is the first device to obtain FDA breakthrough designation for memory ...
In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...
A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...
Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results